ロード中...
Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas
The siglec family of sialic acid-binding proteins are endocytic immune cell receptors that are recognized as potential targets for cell directed therapies. CD33 and CD22 are prototypical members and are validated candidates for targeting acute myeloid leukaemia and non-Hodgkin’s lymphomas due to the...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4048721/ https://ncbi.nlm.nih.gov/pubmed/24921038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/C4SC00451E |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|